Clinical Trials in Mielec, Poland
2 recruiting
Showing 1–2 of 2 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled734 locationsNCT05712200
Recruiting
Not Applicable
Pacemaker Implantation Versus Cardioneuroablation for Functional Atrioventricular Block
Atrioventricular Block
American Heart of Poland300 enrolled2 locationsNCT05774262